Evidens.

Defensive medicine is an American default. Canadian care was never meant to work that way.

Defensive medicine is the practice of ordering tests, imaging, referrals, and treatments not because the patient needs them — but because the physician fears what happens if they don't. It is a rational response to an irrational system. And it is, structurally, an American phenomenon.

That distinction matters for point-of-care clinical tools. A tool built in the US — calibrated to US liability norms, trained on US practice patterns — carries that bias into the clinic. It surfaces options the way a system built around malpractice would think: defensively.

Canadian clinicians deserve something built differently.

What is defensive medicine, and where does it come from?

Defensive medicine describes clinical decision-making shaped primarily by the desire to protect the physician against litigation, rather than by the evidence base for what benefits the patient. When a physician orders imaging for a presentation where clinical guidelines recommend against it — not because the guidelines support it, but because they fear the consequence of missing something — that is defensive medicine.

The term is well-established in medical literature, particularly in the United States. It is a direct response to the structure of US healthcare: a predominantly private, fee-for-service system with significant malpractice liability and no centralized cost-oversight mechanism. In that environment, over-ordering is a rational hedge. The cost of an unnecessary test is modest compared to the cost of a missed finding in court.

Why doesn't defensive medicine translate to Canada?

Canada's healthcare system is structurally different. It is a single-payer public system. The incentive architecture that drives defensive medicine in the US does not map onto Canadian practice in the same way. A single-payer system has different accountability mechanisms — and different incentives around appropriate use of public resources.

This is precisely the context in which Canadian guideline bodies like Choosing Wisely Canada have emerged. Launched in 2014, Choosing Wisely Canada brings together medical specialty societies to identify tests, treatments, and procedures that are frequently used but often not evidence-justified. Its mandate is built on the premise that the Canadian system should order what patients need — and that identifying low-value care is a shared clinical responsibility, not just a health-system accounting problem.

The orientation matters: the Canadian guideline apparatus starts from the evidence, not from liability management.

What happens when Canadian clinicians use tools built for American care?

A point-of-care tool built primarily for the US market reflects the assumptions of that environment. The sources cited, the scenarios surfaced, the way options are framed — all of these carry the imprint of a system where defensive ordering is rational. That creates a quiet friction for Canadian clinicians: the tool suggests one approach; Canadian guidelines suggest another. The clinician has to adjudicate — which means doing the translation work the tool should have done.

This isn't a hypothetical. The volume of US clinical practice data dwarfs the Canadian equivalent, and point-of-care tools trained on that corpus will surface US-calibrated defaults.

Clinical scenario Defensive medicine reflex Evidence-justified care — Canadian guideline orientation
Acute low-back pain, no red flags Early imaging to document and protect against missed-finding claims Conservative management; imaging typically not indicated in the absence of red-flag symptoms
Uncomplicated upper respiratory infection Antibiotic prescription to satisfy expectations and limit complaint risk Targeted antimicrobial use; antibiotics not indicated for viral illness — aligned with Choosing Wisely Canada guidance
Routine visit — unspecific symptoms Extensive bloodwork panel to "rule out" and document Guideline-directed testing; ordered when clinically indicated, not as a reflexive screen
Diagnostic uncertainty Early specialist referral to distribute diagnostic responsibility Guideline-indicated referral; preserves specialist capacity and manages wait times for the system

What does a Canada-native point-of-care tool look like instead?

A tool built for Canadian clinical practice starts from Canadian guidelines — not US liability logic. It surfaces what bodies like Choosing Wisely Canada have already established as evidence-based and appropriate for this system. It doesn't require the clinician to filter out defensive-medicine reflexes or translate US recommendations into a Canadian context.

Every recommendation should be something the clinician can defend on the evidence — not to defend against litigation, but because the evidence supports it.

That is what Evidens is being built to do: operationalize the guideline apparatus that already exists in Canada, at the point of care, in the moment of decision.

Independence note: Evidens is an independent product. It is aligned in spirit with the mandate of Choosing Wisely Canada, CADTH (Canada's Drug Agency), and INESSS. Evidens is not endorsed by, affiliated with, or a product of any of these organizations.

Join the waitlist

Evidens is in private beta with Canadian clinicians. Request early access — for physicians, residents, and pharmacists.


Frequently asked questions

What is defensive medicine?

Defensive medicine describes clinical decisions made primarily to protect the physician from litigation — ordering tests, imaging, or referrals not because they are evidence-indicated but as a liability safeguard. It is most commonly described in the US healthcare context, where malpractice exposure and fee-for-service incentives create structural pressure toward over-ordering.

Does Choosing Wisely Canada address unnecessary ordering?

Yes. Choosing Wisely Canada's mandate is to help clinicians and patients identify tests, treatments, and procedures that are commonly used but may not be necessary or evidence-justified in a given clinical context. The campaign partners with medical specialty societies to develop specific recommendations across dozens of clinical domains.

Is Evidens affiliated with Choosing Wisely Canada?

No. Evidens is an independent product. It is aligned in spirit with Choosing Wisely Canada's focus on evidence-based, appropriate care, but is not affiliated with, endorsed by, or a product of Choosing Wisely Canada or any of its partner organizations.